RET and medullary thyroid gland carcinoma: For example, approximately one in 1750 individuals was observed to harbor a pathogenic ret proto-oncogene (RET) allele (Fig. 2B), compared with an estimated prevalence of MEN2/familial medullary thyroid cancer of approximately one in 80,000 [20].